XML 25 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Meda License, Development and Supply Agreements (Details Textual) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2010
Oct. 31, 2009
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Dec. 31, 2011
Jun. 30, 2012
ONSOLIS [Member]
Jun. 30, 2011
ONSOLIS [Member]
Jun. 30, 2012
U.S. [Member]
Jun. 30, 2012
EU [Member]
May 21, 2012
EU [Member]
ONSOLIS [Member]
Jun. 30, 2012
Milestones [Member]
EU [Member]
Jun. 30, 2012
Research and development [Member]
EU [Member]
Jun. 30, 2012
Maximum [Member]
Jun. 30, 2012
Minimum [Member]
Jun. 30, 2012
Minimum [Member]
ONSOLIS [Member]
Meda License Development and Supply Agreement (Textual) [Abstract]                                  
Aggregate Revenues     $ 15,049,600 $ 38,406 $ 45,113,400 $ 267,868                      
Additional revenues in milestones         2,500,000                        
Deferred contract     16,555,520   16,555,520   14,154,720           16,600,000 15,000,000      
Estimated portion of upfront payments 300,000                 1,500,000 100,000            
Product royalties              34,225 1,000,000 0 30,000                
Cost of product royalties     375,000 (425,930) 750,000 (128,510)   800,000 (100,000)                
Estimated cost in connection to reformulation project                             800,000 600,000 600,000
Pre-launch milestone payment received                       2,500,000          
Credit to cost of product royalties                 400,000                
Minimum royalty payments not paid                 750,000                
Meda License Development and Supply Agreement (Additional Textual) [Abstract]                                  
Aggregate milestones and services revenue recognized   59,800,000                              
Estimated revenue in milestones to be recognized         17,600,000                        
Deferred contract     $ 16,555,520   $ 16,555,520   $ 14,154,720           $ 16,600,000 $ 15,000,000